KeyCorp Cuts UnitedHealth Group (NYSE:UNH) Price Target to $575.00

UnitedHealth Group (NYSE:UNH) had its price target reduced by research analysts at KeyCorp from $650.00 to $575.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the healthcare conglomerate’s stock. KeyCorp’s price objective indicates a potential upside of 33.68% from the stock’s previous close.

Other research analysts have also issued research reports about the stock. Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday. Erste Group Bank raised UnitedHealth Group to a “strong-buy” rating in a report on Wednesday, April 16th. Truist Financial lifted their price target on shares of UnitedHealth Group from $610.00 to $660.00 and gave the stock a “buy” rating in a research note on Friday, April 11th. Barclays reduced their price objective on shares of UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating for the company in a report on Monday. Finally, Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and four have given a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $619.05.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded down $23.98 on Monday, reaching $430.13. 4,252,542 shares of the stock were exchanged, compared to its average volume of 4,366,563. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a fifty day moving average price of $512.95 and a two-hundred day moving average price of $539.93. The stock has a market cap of $393.44 billion, a PE ratio of 27.75, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group has a twelve month low of $427.22 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the firm earned $6.91 earnings per share. Sell-side analysts anticipate that UnitedHealth Group will post 29.54 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Howard Capital Management Group LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $341,000. Principal Financial Group Inc. lifted its holdings in shares of UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock worth $1,039,933,000 after acquiring an additional 180,479 shares during the last quarter. McIlrath & Eck LLC grew its holdings in shares of UnitedHealth Group by 8.2% during the 3rd quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate’s stock valued at $371,000 after purchasing an additional 48 shares during the last quarter. SOA Wealth Advisors LLC. boosted its position in UnitedHealth Group by 3.7% in the third quarter. SOA Wealth Advisors LLC. now owns 1,275 shares of the healthcare conglomerate’s stock valued at $746,000 after buying an additional 46 shares in the last quarter. Finally, Tudor Financial Inc. acquired a new position in shares of UnitedHealth Group during the third quarter worth $900,000. Institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.